Related Experiment Videos

Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia

G Ravaglia1, P Forti, F Maioli

  • 1Department of Internal Medicine, Cardioangiology, and Hepatology, University Hospital S. Orsola-Malpighi, Bologna 40138, Italy.

Insights

Elevated total homocysteine (tHcy) and C-reactive protein (CRP) are linked in older adults with comorbidities, suggesting poor health rather than specific vascular inflammation.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Neurology

Background:

  • Elevated plasma total homocysteine (tHcy) is implicated in cardiovascular diseases (CVD) and dementia.
  • Serum C-reactive protein (sCRP) is a marker for low-grade inflammation, but its association with tHcy is unclear.
  • Comorbidities like chronic obstructive pulmonary disease (CPOD) and peptic ulcer (PU) are common in older adults.

Purpose of the Study:

  • To investigate the association between plasma tHcy and sCRP in older adults.
  • To examine if this association differs in healthy aging, CVD, and dementia.
  • To determine if comorbid CPOD or PU modifies the tHcy-sCRP relationship.

Main Methods:

  • Cross-sectional study of 627 individuals aged 65+.
  • Participants included healthy controls, CVD patients (with and without comorbidities), and dementia patients.
  • Statistical analysis controlled for confounders like age, sex, socio-demographic status, and vascular risk factors.

Main Results:

  • A significant positive association between plasma tHcy and sCRP was observed in CVD patients with comorbidities (CVD+/comorbidity+) and dementia patients (p=0.001).
  • This association was independent of several potential confounders.
  • No significant association was found in healthy controls or CVD patients without comorbidities (CVD+/comorbidity-).

Conclusions:

  • The link between plasma tHcy and sCRP in older adults appears to be an indicator of general poor health, particularly in the presence of comorbidities.
  • This association is not a specific correlate of vascular inflammation in the studied groups.
  • Findings suggest a broader health status marker rather than a direct link to vascular inflammation mechanisms.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...